11 The core concept of the most-favored-nation approach is that patients in the United States should not pay more for prescription drugs than the lowest price negotiated by other wealthy countries
The third bullet at the top of that release is the part I think actually matters, and almost nobody asked what it would take for Lilly to be able to say it: Lilly plans to submit a Biologics License Application (BLA) for retatrutide to FDA in Q1 2027. A Biologics License Application is not the paperwork that produced Zepbound, Mounjaro, Ozempic or Wegovy
Which factornutrition, stress, or speed of weight lossseems most relevant to your situation right now
Supporting fat transport, it helps you access energy stores more efficiently, which can be especially useful when youre in a calorie deficit or pushing hard in the gym
Yes, digestive symptoms including sulfur burps may become more noticeable after a dose increase